• Consensus Rating: Hold
  • Consensus Price Target: $111.52
  • Forecasted Upside: 37.87 %
  • Number of Analysts: 19
  • Breakdown:
  • 1 Sell Ratings
  • 11 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.44 (-0.54%)

This chart shows the closing price for MDT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medtronic Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDT

Analyst Price Target is $111.52
▲ +37.87% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $111.52, with a high forecast of $136.00 and a low forecast of $85.00. The average price target represents a 37.87% upside from the last price of $80.89.

This chart shows the closing price for MDT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 19 contributing investment analysts is to hold stock in Medtronic. This rating has held steady since May 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 11 buy ratings
  • 11 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 12 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 11 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 12 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 13 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 11 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/7/2022Royal Bank of CanadaLower Target$122.00 ➝ $110.00Low
8/24/2022Morgan StanleyLower TargetEqual Weight$103.00 ➝ $101.00Low
8/24/2022Wells Fargo & CompanyLower TargetEqual Weight$104.00 ➝ $96.00Low
8/24/2022Raymond JamesDowngradeOutperform ➝ Market PerformLow
8/23/2022Piper SandlerLower Target$100.00 ➝ $90.00Low
7/20/2022Truist FinancialLower TargetHold$111.00 ➝ $97.00Low
7/18/2022Stifel NicolausLower Target$125.00 ➝ $105.00Low
7/15/2022Morgan StanleyLower TargetEqual Weight$114.00 ➝ $103.00Low
7/5/2022Wolfe ResearchInitiated CoverageUnderperform$85.00N/A
6/7/2022Morgan StanleyLower TargetEqual Weight$115.00 ➝ $114.00Medium
6/1/2022Atlantic SecuritiesDowngradeOverweight ➝ Neutral$125.00 ➝ $105.00Medium
5/31/2022Raymond JamesLower Target$116.00 ➝ $109.00Medium
5/27/2022Truist FinancialLower TargetHold$121.00 ➝ $111.00High
5/27/2022Morgan StanleyLower TargetEqual Weight$120.00 ➝ $115.00High
5/27/2022Royal Bank of CanadaLower Target$135.00 ➝ $122.00Medium
5/27/2022Deutsche Bank AktiengesellschaftLower Target$149.00 ➝ $121.00Low
5/27/2022CitigroupLower TargetBuy$120.00 ➝ $117.00Low
5/27/2022Needham & Company LLCDowngradeBuy ➝ HoldLow
5/26/2022Piper SandlerLower TargetNeutral$105.00 ➝ $100.00Low
5/23/2022CowenSet TargetOutperform$141.00 ➝ $125.00Medium
5/23/2022CowenBoost Target$125.00Medium
5/20/2022Sanford C. BernsteinReiterated RatingBuy$122.00Medium
5/17/2022CitigroupLower Target$127.00 ➝ $120.00N/A
4/13/2022SVB LeerinkReiterated RatingMarket PerformMedium
4/13/2022Truist FinancialDowngradeBuy ➝ Hold$124.00 ➝ $121.00Low
3/1/2022Bank of AmericaInitiated CoverageBuy ➝ BuyHigh
2/23/2022Credit Suisse GroupLower TargetOutperform$142.00 ➝ $135.00Medium
2/23/2022Needham & Company LLCLower TargetBuy$128.00 ➝ $124.00Medium
2/18/2022Raymond JamesLower TargetOutperform$127.00 ➝ $116.00Medium
2/16/2022Piper SandlerLower TargetNeutral$110.00 ➝ $105.00Medium
1/25/2022Needham & Company LLCLower TargetBuy$131.00 ➝ $128.00Low
1/21/2022SVB LeerinkLower TargetMarket Perform$138.00 ➝ $115.00Low
1/19/2022CitigroupLower TargetBuy$130.00 ➝ $129.00Low
1/18/2022The Goldman Sachs GroupLower TargetNeutral$129.00 ➝ $115.00High
1/10/2022BTIG ResearchDowngradeBuy ➝ Neutral$104.00High
1/7/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$145.00 ➝ $120.00Low
1/4/2022Piper SandlerDowngradeOverweight ➝ Neutral$152.00 ➝ $110.00Medium
12/21/2021Truist FinancialLower TargetBuy$142.00 ➝ $124.00Medium
12/20/2021Credit Suisse GroupLower TargetOutperform$146.00 ➝ $142.00Low
12/17/2021OppenheimerLower TargetOutperform$145.00 ➝ $136.00High
12/17/2021BTIG ResearchLower TargetBuy$138.00 ➝ $128.00Medium
12/17/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$130.00 ➝ $105.00Medium
12/16/2021Needham & Company LLCLower TargetBuy$145.00 ➝ $131.00High
12/16/2021Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$137.00 ➝ $110.00High
12/9/2021Royal Bank of CanadaInitiated CoverageOutperform$140.00Low
11/24/2021Truist FinancialLower TargetBuy$148.00 ➝ $142.00Low
11/24/2021Morgan StanleyLower TargetOverweight$154.00 ➝ $145.00Low
11/24/2021Wells Fargo & CompanyLower TargetOverweight$144.00 ➝ $137.00Low
11/24/2021OppenheimerLower TargetOutperform$150.00 ➝ $145.00Low
11/24/2021CitigroupLower TargetBuy$153.00 ➝ $146.00Low
11/23/2021Needham & Company LLCLower TargetBuy$152.00 ➝ $145.00Medium
10/18/2021Wells Fargo & CompanyLower TargetPositive ➝ Overweight$151.00 ➝ $144.00High
8/27/2021ArgusBoost TargetPositive ➝ Buy$150.00 ➝ $165.00Low
8/25/2021Truist FinancialBoost TargetBuy$138.00 ➝ $148.00Low
8/25/2021Credit Suisse GroupBoost TargetOutperform$137.00 ➝ $146.00Medium
8/25/2021Wells Fargo & CompanyBoost TargetOverweight$140.00 ➝ $151.00Medium
8/25/2021Raymond JamesBoost TargetOutperform$135.00 ➝ $142.00Medium
8/25/2021Stifel NicolausBoost TargetBuy$140.00 ➝ $145.00Medium
8/25/2021UBS GroupBoost TargetBuy$145.00 ➝ $149.00Medium
8/25/2021Morgan StanleyBoost TargetPositive ➝ Overweight$140.00 ➝ $154.00Medium
8/25/2021CitigroupReiterated RatingFocus List$143.00 ➝ $153.00Medium
8/24/2021Piper SandlerReiterated RatingOverweight$140.00 ➝ $152.00Medium
8/9/2021BTIG ResearchDowngradeBuy ➝ NeutralLow
6/3/2021ArgusBoost TargetBuy$135.00 ➝ $150.00Low
5/28/2021SVB LeerinkBoost TargetMarket Perform$129.00 ➝ $138.00Medium
5/28/2021Raymond JamesBoost TargetOutperform$128.00 ➝ $135.00Medium
5/28/2021OppenheimerBoost TargetOutperform$134.00 ➝ $147.00Low
5/28/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$134.00 ➝ $149.00Medium
5/28/2021CitigroupReiterated RatingBuy$133.00 ➝ $143.00Medium
5/27/2021William BlairReiterated RatingMarket PerformN/A
5/27/2021Piper SandlerBoost TargetPositive ➝ Overweight$130.00 ➝ $140.00High
5/24/2021BarclaysInitiated CoverageEqual Weight$145.00Low
4/15/2021Atlantic SecuritiesInitiated CoverageOverweight$153.00Medium
3/2/2021SVB LeerinkBoost TargetMarket Perform$123.00 ➝ $129.00Low
2/25/2021Raymond JamesBoost TargetOutperform$122.00 ➝ $128.00Low
2/25/2021Credit Suisse GroupBoost TargetOutperform$126.00 ➝ $130.00Low
2/24/2021CowenBoost TargetOutperform$120.00 ➝ $135.00Low
2/24/2021SVB LeerinkReiterated RatingMarket Perform$123.00 ➝ $129.00Low
2/24/2021Stifel NicolausBoost TargetBuy$132.00 ➝ $135.00Low
12/15/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$100.00 ➝ $119.00Low
12/15/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$140.00Low
11/25/2020Truist FinancialBoost TargetMarket Perform ➝ Buy$128.00Low
11/25/2020Smith Barney CitigroupBoost Target$120.00 ➝ $128.00Low
11/25/2020UBS GroupBoost TargetBuy$123.00 ➝ $130.00Low
11/25/2020Credit Suisse GroupBoost TargetPositive ➝ Outperform$118.00 ➝ $126.00Low
11/25/2020OppenheimerBoost TargetOutperform$122.00 ➝ $128.00Low
11/25/2020Raymond JamesBoost TargetOutperform$115.00 ➝ $122.00Low
11/25/2020Morgan StanleyBoost TargetEqual Weight$111.00 ➝ $120.00Low
11/25/2020Stifel NicolausBoost TargetPositive ➝ Buy$125.00 ➝ $132.00Low
11/25/2020BTIG ResearchBoost TargetBuy$119.00 ➝ $124.00Low
11/25/2020SVB LeerinkBoost TargetMarket Perform$110.00 ➝ $123.00Low
11/24/2020Piper SandlerBoost TargetOverweight$120.00 ➝ $130.00Low
11/18/2020Wells Fargo & CompanyBoost TargetPositive ➝ Overweight$118.00 ➝ $127.00Medium
10/15/2020Jefferies Financial GroupBoost TargetBuy$120.00 ➝ $138.00Low
10/8/2020Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
10/8/2020Stifel NicolausUpgradeHold ➝ Buy$125.00Low
9/11/2020Wolfe ResearchInitiated CoveragePeer Perform$115.00Low
8/26/2020BTIG ResearchBoost TargetBuy$102.00 ➝ $111.00Low
8/26/2020SVB LeerinkBoost TargetMarket Perform$105.00 ➝ $110.00Low
8/26/2020Morgan StanleyBoost TargetEqual Weight$106.00 ➝ $111.00Low
8/26/2020Credit Suisse GroupBoost TargetOutperform$117.00 ➝ $118.00Low
8/26/2020Raymond JamesBoost TargetOutperform$107.00 ➝ $115.00Medium
8/26/2020CitigroupBoost TargetBuy$108.00 ➝ $120.00Low
8/25/2020OppenheimerReiterated RatingBuy$112.00Low
8/25/2020Needham & Company LLCBoost TargetBuy$113.00 ➝ $124.00Low
8/18/2020CowenReiterated RatingBuy$110.00Low
8/11/2020Piper SandlerReiterated RatingBuy$120.00Medium
7/15/2020Needham & Company LLCReiterated RatingBuy$113.00Low
7/2/2020Credit Suisse GroupReiterated RatingBuy$117.00N/A
5/27/2020SunTrust BanksLower Target$130.00 ➝ $105.00Medium
5/23/2020CSFBReiterated RatingBuy$117.00N/A
5/22/2020Credit Suisse GroupReiterated RatingBuy$117.00N/A
5/22/2020Bank of AmericaReiterated RatingBuy$130.00N/A
5/22/2020Jefferies Financial GroupBoost TargetBuy$110.00 ➝ $120.00Medium
5/22/2020OppenheimerLower TargetOutperform$131.00 ➝ $112.00Medium
5/22/2020UBS GroupLower TargetBuy$130.00 ➝ $118.00Medium
5/22/2020Morgan StanleyLower TargetEqual Weight$112.00 ➝ $106.00Medium
5/22/2020Raymond JamesLower TargetOutperform$110.00 ➝ $107.00Medium
5/22/2020Deutsche Bank AktiengesellschaftLower TargetBuy$123.00 ➝ $118.00Medium
5/21/2020OppenheimerInitiated CoverageBuy$131.00Low
5/21/2020Needham & Company LLCReiterated RatingBuy$113.00Low
5/21/2020Piper SandlerLower TargetOverweight$135.00 ➝ $120.00Low
5/21/2020CfraUpgradeBuy ➝ Strong-Buy$127.00 ➝ $121.00Low
5/14/2020DZ BankDowngradeBuy ➝ Hold$92.00Low
4/28/2020SVB LeerinkBoost TargetMarket Perform$100.00 ➝ $105.00Medium
4/23/2020Sanford C. BernsteinReiterated RatingHold$112.00Medium
4/22/2020Needham & Company LLCReiterated RatingBuy$109.00Low
4/22/2020Wells Fargo & CompanyLower TargetOverweight$130.00 ➝ $108.00High
4/9/2020JPMorgan Chase & Co.Lower TargetOverweight$128.00 ➝ $115.00Medium
4/9/2020Raymond JamesLower TargetOutperform$122.00 ➝ $110.00Medium
3/30/2020SunTrust BanksReiterated RatingBuy$130.00High
3/30/2020BTIG ResearchLower TargetHold ➝ Buy$124.00 ➝ $102.00Low
3/30/2020Needham & Company LLCDowngradeStrong-Buy ➝ Buy$134.00 ➝ $109.00Low
3/27/2020Morgan StanleyLower TargetEqual Weight$123.00 ➝ $112.00Low
3/27/2020CitigroupLower TargetBuy$124.00 ➝ $105.00Low
3/25/2020DZ BankUpgradeHold ➝ Buy$90.00High
3/6/2020Credit Suisse GroupLower TargetOutperform$126.00 ➝ $121.00Low
3/4/2020CitigroupInitiated CoverageBuy$124.00Medium
2/19/2020Raymond JamesBoost TargetOutperform$121.00 ➝ $122.00Low
2/19/2020BTIG ResearchLower TargetBuy$126.00 ➝ $124.00Low
2/18/2020Piper SandlerReiterated RatingBuy$135.00Low
2/18/2020CfraBoost TargetBuy$126.00 ➝ $127.00Medium
2/17/2020Credit Suisse GroupReiterated RatingBuy$126.00High
2/12/2020The Goldman Sachs GroupInitiated CoverageSell$118.00Medium
1/22/2020Piper SandlerBoost TargetOverweight$125.00 ➝ $135.00Low
1/16/2020UBS GroupBoost TargetBuy$127.00 ➝ $130.00Medium
1/7/2020SunTrust BanksInitiated CoverageBuy$130.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$99.00Low
1/2/2020CitigroupDowngradeBuy ➝ NeutralMedium
1/2/2020GuggenheimUpgradeNeutral ➝ Buy$135.00Low
12/20/2019JPMorgan Chase & Co.Boost TargetOverweight$122.00 ➝ $128.00Low
12/17/2019Morgan StanleyBoost TargetEqual Weight$116.00 ➝ $123.00Low
11/25/2019ArgusBoost TargetBuy$135.00Low
11/20/2019Royal Bank of CanadaBoost TargetOutperform$118.00 ➝ $122.00Medium
11/20/2019OppenheimerBoost TargetOutperform$118.00 ➝ $123.00Medium
11/20/2019Deutsche Bank AktiengesellschaftBoost TargetBuy$118.00 ➝ $123.00Low
11/19/2019Piper Jaffray CompaniesBoost TargetOverweight$125.00Low
8/28/2019Needham & Company LLCReiterated RatingBuy$133.00Low
8/21/2019Bank of AmericaSet TargetBuy$118.00Medium
8/21/2019OppenheimerBoost TargetOutperform$110.00 ➝ $118.00Low
8/21/2019BMO Capital MarketsBoost TargetOutperform$107.00 ➝ $118.00Low
8/21/2019BarclaysBoost TargetOverweight$110.00 ➝ $117.00Low
8/21/2019Morgan StanleyBoost TargetEqual Weight$105.00 ➝ $111.00Low
8/21/2019UBS GroupBoost TargetOverweight ➝ Buy$112.00 ➝ $122.00Low
8/21/2019Raymond JamesBoost TargetOutperform$105.00 ➝ $118.00Low
8/21/2019Wells Fargo & CompanyBoost TargetOutperform$110.00 ➝ $120.00Low
8/21/2019Stifel NicolausBoost TargetHold$95.00 ➝ $112.00Low
8/21/2019BTIG ResearchBoost TargetBuy$120.00Low
8/21/2019Northland SecuritiesReiterated RatingHold$100.00Low
8/19/2019Deutsche Bank AktiengesellschaftBoost TargetBuy$100.00 ➝ $111.00Low
8/16/2019Royal Bank of CanadaSet TargetBuy$110.00Low
8/14/2019Morgan StanleyBoost TargetEqual Weight$100.00 ➝ $105.00Low
8/14/2019CowenReiterated RatingOutperform$99.00 ➝ $111.00Medium
7/23/2019Needham & Company LLCReiterated RatingBuyLow
7/15/2019OppenheimerSet TargetBuy$110.00Low
7/11/2019BarclaysBoost TargetOverweight$104.00 ➝ $110.00Low
6/20/2019Northland SecuritiesReiterated RatingHold$100.00Low
6/14/2019UBS GroupBoost TargetBuy$112.00Low
6/4/2019Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$100.00 ➝ $110.00Medium
5/28/2019Royal Bank of CanadaLower TargetOutperform$100.00Medium
5/27/2019Needham & Company LLCReiterated RatingBuy$121.00Medium
4/4/2019Wells Fargo & CompanyLower TargetMarket Perform ➝ Market Perform$101.00 ➝ $100.00Low
3/18/2019Northland SecuritiesReiterated RatingHold$84.00Low
2/25/2019CitigroupBoost TargetNeutral ➝ Neutral$95.00 ➝ $101.00Low
2/20/2019BarclaysReiterated RatingBuy$104.00Low
2/20/2019OppenheimerSet TargetBuy$104.00Low
2/4/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$120.00 ➝ $117.00Low
1/15/2019BTIG ResearchUpgradeNeutral ➝ Buy$100.00Low
1/8/2019BarclaysLower TargetOverweight ➝ Overweight$113.00 ➝ $104.00Low
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$99.00High
1/2/2019Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$98.00 ➝ $102.00Low
1/2/2019CitigroupDowngradeBuy ➝ Neutral$109.00 ➝ $96.00Medium
12/19/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$100.00 ➝ $109.00High
12/17/2018Credit Suisse GroupInitiated CoverageBuy ➝ Outperform$109.00 ➝ $109.00Low
11/28/2018UBS GroupInitiated CoverageBuy ➝ Buy$112.00Medium
11/21/2018Raymond JamesLower TargetOutperform ➝ Outperform$105.00 ➝ $104.00Medium
11/20/2018OppenheimerReiterated RatingBuy$104.00Medium
10/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$113.00Medium
10/8/2018ArgusBoost TargetBuy ➝ Buy$108.00 ➝ $120.00Medium
10/3/2018Royal Bank of CanadaBoost TargetOutperform$109.00Low
9/21/2018OppenheimerReiterated RatingBuyMedium
8/27/2018ArgusBoost TargetBuy ➝ Buy$95.00 ➝ $108.00Low
8/24/2018SunTrust BanksBoost TargetBuy$110.00Low
8/24/2018CitigroupBoost TargetBuy ➝ Buy$104.00 ➝ $109.00Low
8/22/2018Bank of AmericaBoost TargetBuy ➝ Buy$98.00 ➝ $105.00Low
8/22/2018SVB LeerinkBoost TargetMarket Perform$95.00 ➝ $100.00Low
8/22/2018Royal Bank of CanadaBoost TargetOutperform$104.00Low
8/22/2018BMO Capital MarketsBoost TargetOutperform ➝ Outperform$94.00 ➝ $104.00Low
8/22/2018Wells Fargo & CompanyBoost TargetMarket Perform ➝ Market Perform$95.00 ➝ $101.00Low
8/22/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$95.00 ➝ $105.00Low
8/22/2018Stifel NicolausBoost TargetHold ➝ Hold$87.00 ➝ $96.00Low
8/21/2018OppenheimerReiterated RatingBuy$104.00High
8/13/2018Needham & Company LLCUpgradeBuy ➝ Strong-Buy$103.00 ➝ $119.00Low
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$88.00Medium
6/6/2018William BlairInitiated CoverageOutperform ➝ Market PerformLow
6/6/2018OppenheimerSet TargetBuy$96.00Low
6/6/2018Needham & Company LLCBoost TargetBuy$97.00 ➝ $103.00Low
5/31/2018Raymond JamesInitiated CoverageOutperform$96.00Low
5/25/2018Piper Jaffray CompaniesBoost TargetOverweight$96.00Low
5/25/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$90.00 ➝ $95.00Low
5/24/2018OppenheimerReiterated RatingBuy$96.00Medium
5/21/2018SunTrust BanksBoost TargetBuy$96.00Low
4/27/2018Piper Jaffray CompaniesInitiated CoverageOverweight$90.00Medium
3/29/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$95.00 ➝ $90.00Medium
3/20/2018OppenheimerReiterated RatingBuyLow
2/22/2018CitigroupReiterated RatingBuy ➝ Buy$100.00 ➝ $93.00Low
2/20/2018OppenheimerReiterated RatingBuy$94.00Low
2/14/2018Royal Bank of CanadaReiterated RatingOutperform$92.00Medium
2/5/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$91.00 ➝ $95.00High
1/19/2018OppenheimerSet TargetBuy$94.00Low
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$92.50High
1/2/2018Bank of AmericaUpgradeNeutral ➝ BuyHigh
12/21/2017OppenheimerReiterated RatingBuyLow
12/12/2017ArgusUpgradeHold ➝ Buy$81.27 ➝ $95.00Low
12/12/2017BMO Capital MarketsBoost TargetOutperform$94.00Low
11/23/2017Jefferies Financial GroupReiterated RatingBuy$99.00N/A
11/22/2017Northland SecuritiesReiterated RatingHold$80.00N/A
11/22/2017OppenheimerReiterated RatingBuy$94.00N/A
11/22/2017Stifel NicolausBoost TargetHold$83.00 ➝ $85.00N/A
11/19/2017SunTrust BanksSet TargetBuy$92.00N/A
11/9/2017Needham & Company LLCReiterated RatingBuy$94.00N/A
11/3/2017SunTrust BanksReiterated RatingBuy$96.00N/A
11/3/2017CowenReiterated RatingBuy$95.00N/A
10/10/2017BMO Capital MarketsReiterated RatingOutperform$92.00 ➝ $89.00N/A
10/10/2017Needham & Company LLCLower TargetBuy$95.00 ➝ $94.00N/A
10/9/2017SVB LeerinkReiterated RatingMarket Perform$88.00 ➝ $85.00N/A
10/9/2017Stifel NicolausLower TargetHold$91.00 ➝ $83.00N/A
10/9/2017Royal Bank of CanadaLower TargetOutperform ➝ Outperform$90.00 ➝ $85.00N/A
10/9/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$93.00 ➝ $83.00N/A
10/2/2017SunTrust BanksReiterated RatingBuy$96.00Low
9/28/2017Jefferies Financial GroupReiterated RatingBuy$96.00Low
(Data available from 9/27/2017 forward)

News Sentiment Rating

0.26 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 7 very positive mentions
  • 23 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
  • 12 very positive mentions
  • 38 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
  • 8 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 9 very positive mentions
  • 25 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
  • 2 very positive mentions
  • 33 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 8 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 7 very positive mentions
  • 31 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
  • 10 very positive mentions
  • 63 positive mentions
  • 12 negative mentions
  • 2 very negative mentions

Current Sentiment

  • 10 very positive mentions
  • 63 positive mentions
  • 12 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

Medtronic logo
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $80.89
Low: $80.39
High: $82.39

50 Day Range

MA: $90.45
Low: $80.89
High: $95.31

52 Week Range

Now: $80.89
Low: $80.39
High: $128.85


5,096,399 shs

Average Volume

6,090,300 shs

Market Capitalization

$107.52 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Medtronic?

The following sell-side analysts have issued research reports on Medtronic in the last year: Atlantic Securities, Bank of America Co., BTIG Research, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for MDT.

What is the current price target for Medtronic?

21 Wall Street analysts have set twelve-month price targets for Medtronic in the last year. Their average twelve-month price target is $111.52, suggesting a possible upside of 37.9%. Oppenheimer Holdings Inc. has the highest price target set, predicting MDT will reach $136.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $85.00 for Medtronic in the next year.
View the latest price targets for MDT.

What is the current consensus analyst rating for Medtronic?

Medtronic currently has 1 sell rating, 11 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MDT, but not buy more shares or sell existing shares.
View the latest ratings for MDT.

What other companies compete with Medtronic?

Other companies that are similar to Medtronic include Elevance Health, Amgen, Sanofi, Stryker and Gilead Sciences. Learn More about companies similar to Medtronic.

How do I contact Medtronic's investor relations team?

Medtronic's physical mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company's listed phone number is (531) 438-1700 and its investor relations email address is [email protected] The official website for Medtronic is www.medtronic.com. Learn More about contacing Medtronic investor relations.